Be Seen – Get Involved
ONdrugDelivery provides >30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma and biotechnology industry professionals who need to know what’s going on in drug delivery.
ONdrugDelivery’s readers have a predefined commercial interest in drug delivery – gain a presence in ONdrugDelivery to engage with them.
How to gain a presence in ONdrugDelivery
If your company’s activities are a fit with ONdrugDelivery’s specialist topics, and you need to access, engage and generate qualified leads from ONdrugDelivery’s readers, there are various ways of gaining a presence:
1. Become an issue sponsor
|Sponsorship in ONdrugDelivery includes: an article (which can promote a specific product, technology or service offering) PLUS a magazine advert PLUS a web advert PLUS a range of additional branding, marketing and lead-generation benefits across ONdrugDelivery’s global digital, magazine issue (print/PDF/e-reader) and social channels.|
Sponsorship is a powerful and effective method of not only getting your technical, scientific, strategic and commercial messages across in full to the people you want to reach, but to yield tangible results by engaging with them. The ONdrugDelivery sponsorship package – designed specifically to grab the attention of your potential partners and clients – is an intelligent combination of advertising, branding and editorial which serves to:
Magazine Benefits of Issue Sponsorship
Digital Benefits of Issue Sponsorship
Choose from Magazine Issue Sponsorship + Digital Sponsorship or Digital Only Sponsorship
TOP TIP: UPGRADE TO OUTSTANDING SPONSORSHIP TO SECURE ALL THE PRIME SPOTS FOR YOUR PLACEMENT!
Place a Company, Technology or Product showcase to deliver a detailed profile of your offering to ONdrugDelivery’s readers:
Magazine Showcase Benefits
Take ownership of a two-page spread in the issue to showcase your offering. In addition to your showcase text and images, you can include an advertisement on the page too (for example a half- or third-page vertical, usually on right hand panel). The Magazine Showcase Package comprises:
Digital Showcase Benefits
Choose from Magazine + Digital Showcase or Digital Only Showcase
ONdrugDelivery Magazine can carry double-page spread, full-page, half-page vertical, half-page horizontal, third-of-a-page vertical (one col) and third-of-a-page horizontal advertisements. All ads are colour, by default they are right-hand-page positioned. Specific positioning requirements can always be considered.
Web Banner Advertisements
Our digital advertising offering is focused on quality. Strictly limited positions are available and artwork with style and of a high standard is required. This ensures maximum quality, engagement, impact and value both of the website experience for our readers and of the space our advertisers purchase.
A limited number of Leaderboard (728x90px) and Skyscraper (120x600px) web ad positions, linking to a URL of your choice (including a tracking URL if desired), with various page-specific positioning options (including specific drug-delivery topic-targeted options) are available for 3 month, 6 month and 12 month runs.
4. Editorial Only (non-promotional)
Non-Promotional Editorial Content
We welcome proposals for non-promotional article contributions. Not associated with advertising or sponsorship, these unbranded, non-paid submissions are of the highest quality and are written by recognised experts in the field. We call these articles Expert Views and Early Insights.
Must be written by experts in the field who can deliver genuine value to readers within the scope of a given issue topic. Articles submitted on this basis are thought-leadership pieces, unbranded and non-promotional, up to 2000 words, and include colour figures/diagrams and contact details. They must be as impartial as possible and must not be promotional / PR pieces. They cannot focus on one company’s product, technology or service offerings but they can mention these in the context of a review of a market or industry sector where other companies’ offerings in the space must also be mentioned.
See examples of previous Expert Views here.
Designed to provide very early-stage commercial and academic innovations a platform, and to inform our readers about technologies at the earliest possible opportunity, Early Insights are up to 2000 words, and include colour figures and diagrams and contact details. There is minimal branding on Early Insights (a small company / university logo in the contact box). Unlike Expert Views, Early Insights can focus on one company’s product, technology or service offering and indeed this is encouraged. Early Insights are open to academic organisations, spinouts and early start-ups. Commercial organisations can only normally submit one Early Insight to ONdrugDelivery and it should be the first or one of the very first times they are publicising the innovation.
See examples of previous Early Insights here.
Expert Views and Early Insights are not paid for content – there are no fees associated with appearing in ONdrugDelivery on this basis.
Please Contact us to find out more.
ONdrugDelivery has a 15 year heritage, an excellent reputation, regular loyal support from leading companies (from the very largest to the very smallest), and a global, engaged, combined print and digital readership.
Each issue of ONdrugDelivery is published:
1. In print and PDF/e-reader
2. In an e-newsletter to >10,000 recipients)
3. Online on our website
4. Via social media (LinkedIn, Twitter and Facebook).
Readership is truly global – core readership geographically predominantly North American and European with a substantial proportion of readers throughout the world’s other major pharma markets (Japan, Israel, Australia, New Zealand and others), and notably a rapidly increasing number in the fast-growing Asian and South American markets.
By job function, most of the readership comprises middle and senior decision makers (executives and scientists) working within the global pharmaceutical, biotechnology, specialty pharma, drug delivery and medical devices industries.
(Regulators, academics, financial analysts, consultants and bankers are also among our readers.)
ONdrugDelivery’s core global Print +Digital readership, wide social media reach, and extensive bonus print conference distribution combine to make a compelling, tightly targeted, truly global promotional value proposal.
In which issues should your company appear?
There are between 10 and 12 issues published per year. For companies providing drug delivery-related products, technologies and services, the publications provide a platform from which to reach new clients and partners. The high level of topic specificity gives an unparalleled degree of targeting.
Issue topics include:
Contact us today to boost your organisation’s B2B marketing and business development performance, driving new sales and partnerships, by featuring your organisation across ONdrugDelivery’s global digital, social and print channels.
Drug delivery is a global industry, ONdrugDelivery’s readership is global, and our reach is global. However, Frederick Furness Publishing is a family owned, highly customer-focused company dealing with niche topics. As such, we have a detailed knowledge of the drug delivery business and a very personal approach to meeting the needs of our sponsors and advertisers.
ONdrugDelivery can help your organisation boost its business development and partnering success!
Find out today how your company can benefit from reaching and engaging ONdrugDelivery’s readers by contacting Guy Furness, ONdrugDelivery’s Founder and Publisher:
T: +44 1273 47 28 28
E: [email protected]